Compare SPDR Gold Trust (GLD) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SPDR Gold Trust vs Hinge Health Inc. Class A Common Stock — how do they compare? SPDR Gold Trust trades at $380.65 (market cap $141.50B), while Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B). The key difference: SPDR Gold Trust is far larger — about 16.7× Hinge Health Inc. Class A Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, SPDR Gold Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SPDR Gold Trust for 75 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| GLD | HNGE | |
|---|---|---|
Market Cap | $141.50B | $8.47B |
Volume | 5,707,251 | 1,624,526 |
52-Week High | $495.90 | $105.14 |
52-Week Low | $362.32 | $31.17 |
Typical Hold Time | 75 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $8.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GLD, the SPDR Gold Trust ETF, trades at $381.67, down 0.13% amid pressure from rising Treasury yields and a stronger U.S. dollar. Technical indicators show a bearish bias with moving averages signaling sell pressure, though oscillators remain neutral. Recent news highlights gold's struggle to maintain momentum despite safe-haven demand, with prices testing key support levels near $380.
The outlook for GLD hinges on interest rate trends and macroeconomic uncertainty. While gold serves as a hedge against inflation and debt concerns, near-term headwinds from elevated yields and Fed policy uncertainty pose risks. A tactical buying opportunity may emerge if support holds, but sustained gains require a shift in monetary policy sentiment.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SPDR Gold Trust
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
